Johnson & Johnson approaches Actelion about takeover deal
Actelion shares surged nearly 19 percent to a peak of 187.70 Swiss francs on Friday, valuing the company at around $20 billion. They closed up 16.8 percent at 184.50 Swiss francs, more than matching the stock’s total gains this year up to Thursday’s close.
J&J’s Actelion Deal Just One More Reason to Buy SharesTheStreet.com
European shares edge lower but head for 3rd week of gainsReuters UK
J&J Said to Make Takeover Approach for Drugmaker ActelionBloomberg
all 78 news articles >>
Source: shares – Google News
Sharing information is key – Share Dealing Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd